Severe Acute Hepatitis B Treated with Entecavir
<pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">Hepatitis B virus (HBV) infection constitutes a serious global health problem. </span></pre><pre style="line-h...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2011-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/article/view/7536 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846095899898413056 |
|---|---|
| author | Andrea Tosti Alessio Sgrelli Giuseppe Vittorio Luigi De Socio Franco Baldelli |
| author_facet | Andrea Tosti Alessio Sgrelli Giuseppe Vittorio Luigi De Socio Franco Baldelli |
| author_sort | Andrea Tosti |
| collection | DOAJ |
| description | <pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">Hepatitis B virus (HBV) infection constitutes a serious global health problem. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">We present here a case of a 62-year-old man affected by severe acute hepatitis B with progressive worsening of clinical and hepatic function. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">The patient was treated with entecavir without critical side effects. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">We observed rapid clinical and laboratory improvements and the disappearance of surface antigen (HBsAg). </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">The treatment with entecavir was protracted until 17<sup>th</sup> week when the antibody antiHBs (anti HBs) appeared. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">Entecavir should be carefully considered for the treatment of severe acute hepatitis B cases.</span></pre> |
| format | Article |
| id | doaj-art-e9dca9e6eebc46868c6f1b31df2a3c1b |
| institution | Kabale University |
| issn | 2035-3006 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Mediterranean Journal of Hematology and Infectious Diseases |
| spelling | doaj-art-e9dca9e6eebc46868c6f1b31df2a3c1b2025-01-02T08:53:27ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062011-01-0131e2011010e2011010Severe Acute Hepatitis B Treated with EntecavirAndrea TostiAlessio SgrelliGiuseppe Vittorio Luigi De SocioFranco Baldelli<pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">Hepatitis B virus (HBV) infection constitutes a serious global health problem. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">We present here a case of a 62-year-old man affected by severe acute hepatitis B with progressive worsening of clinical and hepatic function. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">The patient was treated with entecavir without critical side effects. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">We observed rapid clinical and laboratory improvements and the disappearance of surface antigen (HBsAg). </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">The treatment with entecavir was protracted until 17<sup>th</sup> week when the antibody antiHBs (anti HBs) appeared. </span></pre><pre style="line-height: 200%;"><span style="line-height: 200%; font-family: " lang="EN-GB">Entecavir should be carefully considered for the treatment of severe acute hepatitis B cases.</span></pre>http://www.mjhid.org/article/view/7536Acute Hepatitis B, Entecavir, HBV therapy |
| spellingShingle | Andrea Tosti Alessio Sgrelli Giuseppe Vittorio Luigi De Socio Franco Baldelli Severe Acute Hepatitis B Treated with Entecavir Mediterranean Journal of Hematology and Infectious Diseases Acute Hepatitis B, Entecavir, HBV therapy |
| title | Severe Acute Hepatitis B Treated with Entecavir |
| title_full | Severe Acute Hepatitis B Treated with Entecavir |
| title_fullStr | Severe Acute Hepatitis B Treated with Entecavir |
| title_full_unstemmed | Severe Acute Hepatitis B Treated with Entecavir |
| title_short | Severe Acute Hepatitis B Treated with Entecavir |
| title_sort | severe acute hepatitis b treated with entecavir |
| topic | Acute Hepatitis B, Entecavir, HBV therapy |
| url | http://www.mjhid.org/article/view/7536 |
| work_keys_str_mv | AT andreatosti severeacutehepatitisbtreatedwithentecavir AT alessiosgrelli severeacutehepatitisbtreatedwithentecavir AT giuseppevittorioluigidesocio severeacutehepatitisbtreatedwithentecavir AT francobaldelli severeacutehepatitisbtreatedwithentecavir |